Skip to Main Content

Mavoglurant in Alcohol Drinking

Conditions

Mental Health & Behavioral Research

Phase Pilot

What is the purpose of this trial?

The purpose of this alcohol-interaction pilot study is to provide information on the effect of mavoglurant on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of 200 mg mavoglurant versus placebo on alcohol related responses. This is a between subjects double blind randomized design in which the investigators plan to run 14 subjects to obtain 10 completers.

  • Trial with
    National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • Start Date
    10/09/2020
  • End Date
    02/28/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000021703